Providence Biotherapy Program is the only program in Oregon offering high-dose interleukin-2 (IL-2) immunotherapy to patients with metastatic kidney cancer and metastatic melanoma. Interleukin-2 immunotherapy is an FDA-approved treatment that stimulates a patient’s own immune system to better target and destroy cancer cells. More »